Vanguard Wellington Dividend Growth Active ETF
VDIG - ETF AI Analysis
Top Page
Vanguard Wellington Dividend Growth Active ETF (VDIG)
VDIG’s rating reflects a solid, high-quality mix of companies with strong financial performance and growth potential. Large positions in leaders like Microsoft, Merck, Apple, and Broadcom support the fund’s quality through robust earnings, positive outlooks in cloud, AI, and healthcare, and strong profitability. The main risk factor is that several key holdings trade at high valuations or show bearish/overbought technical signals, which could limit future returns if growth expectations are not met.
VDIG vs. SPDR S&P 500 ETF (SPY)
- AUM
- 32.53M
- Region
- North America
- Expense Ratio
- 0.40%
- Beta
- 0.72
- Issuer
- Vanguard
- Inception Date
- Nov 14, 2025
- Dividend Yield
- 0.12%
- Asset Class
- Equity
- Index Tracked
- No Underlying Index
VDIG Summary
VDIG is the Vanguard Wellington Dividend Growth Active ETF, which focuses on large, established U.S. companies that regularly pay and grow their dividends. Instead of tracking a fixed index, it is actively managed to pick high-quality businesses with strong earnings and steady cash flows. Its holdings include well-known names like Microsoft, Apple, Mastercard, and JPMorgan Chase, spread across technology, financials, health care, and more. Investors might consider VDIG for a mix of long-term growth and rising income from dividends. A key risk is that stock prices and dividend payments can still go up and down with the overall market.
How much will it cost me?
The Vanguard Wellington Dividend Growth Active ETF (VDIG) has an expense ratio of 0.40%, meaning you’ll pay $4 per year for every $1,000 invested. This is higher than average because it is actively managed, requiring more research and decision-making compared to passively managed funds that track an index.
What would affect this ETF?
The Vanguard Wellington Dividend Growth Active ETF (VDIG) could benefit from strong performance in the technology and healthcare sectors, which are key areas of focus for the fund, as well as continued demand for dividend-paying stocks during uncertain economic times. However, rising interest rates or economic slowdowns could negatively impact the financial and consumer cyclical sectors, which also make up a significant portion of the ETF's holdings. Additionally, regulatory changes or geopolitical tensions affecting large-cap U.S. companies could pose risks to the fund's performance.
VDIG Top 10 Holdings
VDIG leans heavily on U.S. blue chips, with Mastercard and Microsoft acting as core engines of growth—Mastercard rising steadily while Microsoft’s momentum has been a bit mixed lately. Health care is another key pillar: Eli Lilly, Merck, and Amgen have been climbing, giving the fund a strong defensive backbone with a growth twist. On the other hand, Broadcom’s recent slide in semiconductors has been a noticeable drag. Overall, the ETF is concentrated in large-cap U.S. tech, financials, and pharma, balancing steady dividend power with selective growth bets.
| Name | Company Name | Weight % | Market Value | Market Cap | Yearly Gain | Overall Rating |
|---|---|---|---|---|---|---|
| Mastercard | 7.88% | $2.61M | $575.61B | 16.28% | 75Outperform | |
| Microsoft | 6.22% | $2.06M | $3.87T | 2.32% | 79Outperform | |
| Eli Lilly & Co | 5.73% | $1.89M | $1.35T | 40.23% | 72Outperform | |
| Broadcom | 4.55% | $1.50M | $1.65T | 2.57% | 76Outperform | |
| JPMorgan Chase | 4.37% | $1.45M | $911.91B | 6.99% | 72Outperform | |
| Merck & Company | 3.92% | $1.30M | $362.83B | 60.69% | 80Outperform | |
| Apple | 3.59% | $1.19M | $5.17T | 29.77% | 79Outperform | |
| BlackRock | 3.30% | $1.09M | $198.70B | 11.21% | 77Outperform | |
| Linde | 2.80% | $926.68K | $241.73B | 21.80% | 66Neutral | |
| Amgen | 2.74% | $905.80K | $253.21B | 38.89% | 77Outperform |
VDIG Technical Analysis
Price Trends
Market Momentum
Evaluating momentum and price trends is crucial in ETF analysis to make informed investment decisions. For VDIG, the sentiment is Positive. The current price of 66.71 is above the 20-day moving average (MA) of 65.58, above the 50-day MA of 63.89, and above the 200-day MA of 61.96, indicating a bullish trend. The MACD of 0.69 indicates Negative momentum. The RSI at 62.05 is Neutral, neither overbought nor oversold. The STOCH value of 79.15 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for VDIG.
VDIG Peer Comparison
Comparison Results
| Name | Price | Price Target | AUM | Expense Ratio | Overall Rating |
|---|---|---|---|---|---|
| $66.71 | $71.00(6.43% Upside) | $32.53M | 0.40% | 69Neutral | |
| $25.10 | $34.13(35.99% Upside) | $94.81M | 0.67% | 75Outperform | |
| $38.66 | $48.25(24.80% Upside) | $86.69M | 0.36% | 75Outperform | |
| $35.61 | $45.54(27.89% Upside) | $85.75M | 0.65% | 75Outperform | |
| $25.91 | $30.75(18.69% Upside) | $75.50M | 0.65% | 68Neutral | |
| $27.01 | $37.19(37.67% Upside) | $72.13M | 0.39% | 72Outperform |
Performance Comparison
| Show on chart | Ticker | Company Name | Price | Change | % Change |
|---|---|---|---|---|---|
| VDIG | Vanguard Wellington Dividend Growth Active ETF | 66.71 | 7.53 | 12.72% | |
| TLG | Touchstone Large Company Growth ETF | 25.09 | 0.59 | 2.40% | |
| PRXG | Praxis Impact Large Cap Growth ETF | 38.66 | 2.52 | 6.97% | |
| AFGR | First Trust Active Factor Large Cap Growth ETF | 35.61 | 0.53 | 1.52% | |
| AQLG | Highland Capital Large Capital Growth ETF | 25.91 | 0.91 | 3.64% | |
| CGGG | Capital Group U.S. Large Growth ETF | 27.01 | -0.99 | -3.55% |
This AI Analyst ETF Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in ETFs carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.
